PepGen Company Overview, Contact Details & Competitors

Insights

Gathering insights about PepGen…

Similar companies to PepGen

PepGen Tech Stack

PepGen uses 8 technology products and services including JazzHR, Adobe Fonts, Font Awesome, and more. Explore PepGen's tech stack below.

JazzHR
Applicant Tracking Systems
Adobe Fonts
Font Scripts
Font Awesome
Font Scripts
Google Font API
Font Scripts
Indeed
Human Resource Management System
Exhibit
Javascript Graphics
WP Engine
Platform As A Service
GraphPad Prism
Visualisation Software

Media & News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Dec 26, 2024 | www.accesswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, NY / ACCESSWIRE / December 24, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Dec 24, 2024 | www.accesswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Dec 17, 2024 | www.accesswire.com
PepGen clinical hold likely to be resolved quickly, says Leerink
PepGen announced that the FDA has placed a clinical hold on the Phase 2 CONNECT2-EDO51 study of PGN-EDO51 in Duchenne muscular dystrophy, while the open-label Phase 2 CONNECT1-EDO51 study continues excluding the U.S. Leerink tells investors in a research note. The firm, which reiterates an Outperform rating, says management does not what the hold is connected to at this time and are waiting for the full letter for details, and notes that the news is reminiscent of what happened to PepGen when they initiated U.S. sites in the Phase 1 FREEDOM-DM1 study of PGN-EDODM1 in myotonic dystrophy type 1. Leerink is optimistic PepGen will be able to resolve the hold relatively quickly.
Dec 16, 2024 | thefly.com
PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced it awarded an inducement grant under PepGen's 2024 Inducement Plan as a material inducement to employment to its newly appointed Senior Vice President, Clinical Development, Steve Han, MD, PhD, MMSc. On November 20, 2024, Dr. Han receive.
Nov 21, 2024 | www.businesswire.com
PepGen to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences: Guggenheim's Inaugural Healthcare Innovation Conference (Boston, MA) Monday, November 11, 2024 at 1:00 p.m. ET, Fireside Chat Stifel 2024 Healthcare Confere.
Nov 04, 2024 | www.businesswire.com
PepGen Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out
LOS ANGELES, CA / ACCESSWIRE / October 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Oct 03, 2024 | www.accesswire.com

PepGen's Email Address Formats

PepGen uses at least 1 format(s):

PepGen Email Formats	Example	Percentage
FLast@pepgen.com	JDoe@pepgen.com	49%
First@pepgen.com	John@pepgen.com	1%
FirstLast@pepgen.com	JohnDoe@pepgen.com	1%
FLast@pepgen.com	JDoe@pepgen.com	49%

Frequently Asked Questions

Where is PepGen's headquarters located?

PepGen's main headquarters is located at 321 Harrison Ave 8th Floor Boston, Massachusetts 02118 US. The company has employees across 2 continents, including North AmericaEurope.

What is PepGen's stock symbol?

PepGen is a publicly traded company; the company's stock symbol is PEPG.

What is PepGen's official website and social media links?

PepGen's official website is pepgen.com and has social profiles on LinkedIn.

How much revenue does PepGen generate?

As of October 2024, PepGen's annual revenue reached $15M.

What is PepGen's SIC code NAICS code?

PepGen's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PepGen have currently?

As of October 2024, PepGen has approximately 85 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: J. M.Chief Financial Officer: N. D.Chief Medical Officer: M. M.. Explore PepGen's employee directory with LeadIQ.

What industry does PepGen belong to?

PepGen operates in the Biotechnology Research industry.

What technology does PepGen use?

PepGen's tech stack includes JazzHRAdobe FontsFont AwesomeGoogle Font APIIndeedExhibitWP EngineGraphPad Prism.

What is PepGen's email format?

PepGen's email format typically follows the pattern of . Find more PepGen email formats with LeadIQ.

How much funding has PepGen raised to date?

As of October 2024, PepGen has raised $158M in funding. The last funding round occurred on Aug 05, 2021 for $113M.

When was PepGen founded?

PepGen was founded in 2018.

Insights

Similar companies to PepGen

Vertex Pharmaceuticals

Sarepta Therapeutics

Prevail Therapeutics

Dyno Therapeutics

Beam Therapeutics

Affinia Therapeutics

Stoke Therapeutics

Rheos Medicines

ProQR Therapeutics

Generation Bio

Dynacure

PepGen Tech Stack

Media & News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

PepGen clinical hold likely to be resolved quickly, says Leerink

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development

PepGen to Participate in Upcoming Investor Conferences

PepGen Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out

PepGen's Email Address Formats

Frequently Asked Questions

Where is PepGen's headquarters located?

What is PepGen's stock symbol?

What is PepGen's official website and social media links?

How much revenue does PepGen generate?

What is PepGen's SIC code NAICS code?

How many employees does PepGen have currently?

What industry does PepGen belong to?

What technology does PepGen use?

What is PepGen's email format?

How much funding has PepGen raised to date?

When was PepGen founded?

PepGen

Company Overview

Media & News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?